Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | SRD5A2 | P31213 | 4/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 2/20 | 0.42 |
| ▸ | CA6 | P23280 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | DRD1 | P21728 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | TPMT | P51580 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4957915 | 0.98 | TSHR (0.48) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL578580 | 0.78 | TSHR (0.52) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL2441945 | 0.76 | CA2 (0.42) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL3906107 | 0.76 | POLB (0.57) | SRD5A2ALDH1A1KDM4EPOLBL3MBTL1 | |
| SCHEMBL185207 | 0.74 | TSHR (0.48) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL6631569 | 0.74 | TSHR (0.48) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL1869090 | 0.74 | ALDH1A1 (0.50) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL4030667 | 0.74 | TPMT (0.44) | TSHRTP53CA1CA2ALOX15 | |
| SCHEMBL16267153 | 0.74 | ALDH1A1 (0.44) | SRD5A2ALDH1A1TPMTSMN1; SMN2CES2 | |
| SCHEMBL3340202 | 0.74 | BCL2L1 (0.40) | TSHRCA1CA2ALDH1A1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116903869-A | Zr-UiO-66-BA material, preparation method, application and saccharomyces cerevisiae concentration detection method | 贵州茅台酒股份有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-114618441-B | Controllable preparation method of MIL material and application of MIL material in separation and enrichment of polyalcohol | 中国科学院大连化学物理研究所 | 2023-07-04 | — | — | CN | claimed |
| US-20220153713-A1 | HYDRAZONE AMIDE DERIVATIVE AND APPLICATION THEREOF IN PREPARATION OF MEDICAMENTS FOR PREVENTING AND TREATING ALOPECIA | SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT CO., LTD. (CN) | 2022-05-19 | — | — | US | claimed |
| US-20220153688-A1 | HYDRAZONE AMIDE DERIVATIVES AND USE THEREOF IN PREPARATION OF ANTI-OSTEOPOROSIS DRUGS | SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT CO., LTD. (CN) | 2022-05-19 | — | — | US | claimed |
| EP-3992184-A1 | HYDRAZONE AMIDE DERIVATIVES AND USE THEREOF IN PREPARATION OF ANTI-OSTEOPOROSIS DRUGS | Shenzhen Cell Inspire Pharmaceutical Development Co., Ltd. (CN) | 2022-05-04 | — | — | EP | claimed |
| EP-3992185-A1 | HYDRAZONE AMIDE DERIVATIVE AND APPLICATION THEREOF IN PREPARATION OF MEDICAMENTS FOR PREVENTING AND TREATING ALOPECIA | Shenzhen Cell Inspire Pharmaceutical Development Co., Ltd. (CN) | 2022-05-04 | — | — | EP | claimed |
| CN-113105411-A | Hydrazone amide derivatives and pharmaceutical compositions | 深圳市三启药物开发有限公司 | 2021-07-13 | — | — | CN | claimed |
| US-8975259-B2 | Compositions and methods for inhibiting G protein signaling | UNIVERSITY OF ROCHESTER (US) | 2015-03-10 | — | — | US | claimed |
| US-20100130505-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2010-05-27 | — | — | US | claimed |
| CN-101687984-A | Solid state polymerization process for polyester | BASF SE | 2010-03-31 | — | — | CN | claimed |
| US-7129264-B2 | Biarylmethyl indolines and indoles as antithromboembolic agents | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-10-31 | — | — | US | claimed |
| EP-1633716-A2 | BIARYLMETHYL INDOLINES, INDOLES AND TETRAHYDROQUINOLINES, USEFUL AS SERINE PROTEASE INHIBITORS | Bristol-Myers Squibb Company (US) | 2006-03-15 | — | — | EP | claimed |
| WO-2004094372-A2 | COMPOUNDS USEFUL AS SERINE PROTEASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-11-04 | — | — | WO | claimed |
| US-20040220206-A1 | Biarylmethyl indolines, indoles and tetrahydroquinolines, useful as serine protease inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2004-11-04 | — | — | US | claimed |
| CN-1127533-C | Catalyst for producing polyester and process for producing polyester using the same | TEIJIN LTD (JP) | 2003-11-12 | — | — | CN | claimed |
| CN-1320135-A | Catalyst for polyester production and process for process for producing polyester with the same | TEIJIN LTD (JP) | 2001-10-31 | — | — | CN | claimed |
| US-5879869-A | HAVING LIGHT-INSENSITIVE HYDROPHILIC COLLOID LAYER EXHIBITING ANTIHALATION EFFECT | FUJI PHOTO FILM CO., LTD (JP) | 1999-03-09 | — | — | US | claimed |
| EP-0458442-B1 | Colorants | BASF AG (DE) | 1997-08-20 | — | — | EP | claimed |
| EP-0476928-A1 | Light-sensitive silver halide photographic material | KONICA CORPORATION (JP) | 1992-03-25 | — | — | EP | claimed |
| US-4774161-A | LITHOGRAPHY, PRINTING PLATES | FUJI PHOTO FILM CO., LTD. (JP) | 1988-09-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040220206-A1 | Biarylmethyl indolines, indoles and tetrahydroquinolines, useful as serine protease inhibitors | TFPI, TFPI2, F2 | TSHR 2875/4885TP53 3506/4885SRD5A2 962/4885 |
| US-20100130505-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | GNAI1, GNAI3, GNAI2 | TSHR 2522/4885TP53 4171/4885SRD5A2 4321/4885 |
| US-20220153688-A1 | HYDRAZONE AMIDE DERIVATIVES AND USE THEREOF IN PREPARATION OF ANTI-OSTEOPOROSIS DRUGS | SOST, HDAC5, PTH1R | TSHR 1218/4885TP53 4852/4885SRD5A2 329/4885 |
| US-20220153713-A1 | HYDRAZONE AMIDE DERIVATIVE AND APPLICATION THEREOF IN PREPARATION OF MEDICAMENTS FOR PREVENTING AND TREATING ALOPECIA | FH, HDGF, HRH4 | TSHR 1288/4885TP53 3487/4885SRD5A2 130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.